![این مقاله در پایگاه ساینس دایرکت منتشر شده است Elsevier - ScienceDirect - الزویر - ساینس دایرکت](/assets/img/Elsevier-Logo.png)
A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults
Keywords: عارضه جانبی یا عوارض جانبی; AE; adverse event; fHBP; factor H binding protein; HAV; hepatitis A virus vaccine; IMD; invasive meningococcal disease; MAE; medically-attended adverse event; MnB; Neisseria meningitidis serogroup B; NDCMC; newly-diagnosed chronic medical condition; SAE;